These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
123 related items for PubMed ID: 7931226
21. Comparative effects of melatonin, L-deprenyl, Trolox and ascorbate in the suppression of hydroxyl radical formation during dopamine autoxidation in vitro. Khaldy H, Escames G, León J, Vives F, Luna JD, Acuña-Castroviejo D. J Pineal Res; 2000 Sep; 29(2):100-7. PubMed ID: 10981823 [Abstract] [Full Text] [Related]
22. Neuroprotective aspects of a novel MAO-B inhibitor PF9601N. Pérez V, Morón J, Pastó M, Unzeta M. Neurobiology (Bp); 2000 Sep; 8(3-4):231-6. PubMed ID: 11225513 [Abstract] [Full Text] [Related]
23. L-Deprenyl and MDL72974 do not improve the recovery of dopaminergic cells following systemic administration of MPTP in mouse. Thiffault C, Lamarre-Théroux L, Quirion R, Poirier J. Brain Res Mol Brain Res; 1997 Mar; 44(2):238-44. PubMed ID: 9073165 [Abstract] [Full Text] [Related]
24. Comparison of the effects of two 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs, 1-methyl-4-(2-thienyl)-1,2,3,6-tetrahydropyridine and 1-methyl-4-(3-thienyl)-1,2,3,6-tetrahydropyridine, on monoamine oxidase in vitro and on dopamine in mouse brain. Fuller RW, Robertson DW, Hemrick-Luecke SK. J Pharmacol Exp Ther; 1987 Feb; 240(2):415-20. PubMed ID: 3100775 [Abstract] [Full Text] [Related]
25. Monoamine oxidase-dependent metabolism of dopamine in the striatum and substantia nigra of L-DOPA-treated monkeys. Di Monte DA, DeLanney LE, Irwin I, Royland JE, Chan P, Jakowec MW, Langston JW. Brain Res; 1996 Oct 28; 738(1):53-9. PubMed ID: 8949927 [Abstract] [Full Text] [Related]
26. Characterization of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) binding sites in C57BL/6 mouse brain: mutual effects of monoamine oxidase inhibitors and sigma ligands on MPTP and sigma binding sites. Itzhak Y, Mash D, Zhang SH, Stein I. Mol Pharmacol; 1991 Mar 28; 39(3):385-93. PubMed ID: 1848660 [Abstract] [Full Text] [Related]
27. PF 9601N [N-(2-propynyl)-2-(5-benzyloxy-indolyl) methylamine], a new MAO-B inhibitor, attenuates MPTP-induced depletion of striatal dopamine levels in C57/BL6 mice. Perez V, Unzeta M. Neurochem Int; 2003 Feb 28; 42(3):221-9. PubMed ID: 12427476 [Abstract] [Full Text] [Related]
28. SKF-38393, a dopamine receptor agonist, attenuates 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity. Muralikrishnan D, Ebadi M. Brain Res; 2001 Feb 23; 892(2):241-7. PubMed ID: 11172770 [Abstract] [Full Text] [Related]
29. Influence of monoamine oxidase inhibitors on striatonigral dynorphin system: a study with deprenyl and clorgyline. Sivam SP. Neuropeptides; 1993 Jul 23; 25(1):35-45. PubMed ID: 7692341 [Abstract] [Full Text] [Related]
30. The effects of monoamine oxidase inhibition and dopamine uptake blockade on MPTP-induced increase of 2-[3H]deoxyglucose uptake in specific mesencephalic catecholaminergic nuclei. Hess A. Neurosci Lett; 1990 Apr 20; 112(1):7-13. PubMed ID: 2143566 [Abstract] [Full Text] [Related]
31. Deprenyl antagonizes acute lethality of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. Fuller RW, Hemrick-Luecke SK, Perry KW. J Pharmacol Exp Ther; 1988 Nov 20; 247(2):531-5. PubMed ID: 3141609 [Abstract] [Full Text] [Related]
36. Genetic elevation of monoamine oxidase levels in dopaminergic PC12 cells results in increased free radical damage and sensitivity to MPTP. Wei Q, Yeung M, Jurma OP, Andersen JK. J Neurosci Res; 1996 Dec 15; 46(6):666-73. PubMed ID: 8978500 [Abstract] [Full Text] [Related]
37. Differential effects of L-deprenyl on MPP+- and MPTP-induced dopamine overflow in microdialysates of striatum and nucleus accumbens. Wu WR, Zhu ZT, Zhu XZ. Life Sci; 2000 Jun 08; 67(3):241-50. PubMed ID: 10983868 [Abstract] [Full Text] [Related]